Access to health data for secondary uses that serve the public interest can improve health outcomes, strengthen health system performance and support healthcare innovation. When combined with responsible and trustworthy AI, such data can generate new insights, enhance decision-making and help address complex health challenges. However, enabling access and re-use while safeguarding privacy requires robust governance and careful review by authorised bodies. Today, a lack of clear definitions and differing approaches across review bodies can create barriers to data access and impede collaboration within and across countries. This policy brief identifies five broad categories of criteria relevant to assessing public interest: population health and planning; research and innovation; ethical and risk considerations; health equity; and public communication and transparency. It also outlines approaches to help policymakers enable more consistent, trusted and effective health data governance.
Share
Facebook
Twitter
LinkedIn
Abstract
In the same series
-
Policy brief
Lessons from fertilisers
19 October 20267 Pages -
15 October 202615 Pages
-
Policy brief
Evidence from innovative start‑ups in the EU and the US
8 October 20267 Pages -
18 September 20266 Pages
Related publications
-
7 October 202639 Pages -
Working paper
Insights into structures and solutions for public access and use
8 December 202557 Pages -
Working paper
Leading practices in immunisation reporting and respiratory disease surveillance
6 November 202598 Pages